[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.158.83.210. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
January 14, 2009

Thyroid-Stimulating Hormone–Receptor Antibody and Thyroid Hormone Concentrations in Smokers vs Nonsmokers With Graves Disease Treated With Carbimazole

JAMA. 2009;301(2):162-164. doi:10.1001/jama.2008.931

To the Editor: Cigarette smoking increases the risk of complications of Graves disease, such as ophthalmopathy and relapse after treatment with antithyroid drugs.1 Anecdotally, patients with Graves disease who smoke appear to respond more slowly to treatment with carbimazole. We therefore retrospectively compared the decline in concentrations of thyroid-stimulating hormone (TSH)–receptor antibody and thyroid hormones in smokers and nonsmokers during carbimazole therapy.

First Page Preview View Large
First page PDF preview
First page PDF preview
×